Genomic Investigation of Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae: Resistance, Virulence, and Genetic Diversity
Indus Journal of Bioscience Research · 10.03.2026 · 4 (3.1) · 70-75
DOI: 10.70749/ijbr.v4i3.1.3354 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indus Journal of Bioscience Research, online erschienen am 10.03.2026. Verfasst von Afra und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-hvKP) has emerged as a serious global health threat due to the convergence of multidrug resistance, enhanced virulence, and rapid dissemination of high-risk clones. This study investigated the antimicrobial resistance patterns, carbapenemase genes, virulence-associated determinants, and genetic diversity of CR-hvKP using molecular approaches and whole-genome sequencing (WGS). A total of 120 non-duplicate clinical specimens were investigated, yielding 78 (65.0%) K. pneumoniae isolates, of which 42/78 (53.8%) were carbapenem resistant. Among these, 24/42 (57.1%) carried major hypervirulence-associated determinants and were categorized as candidate CR-hvKP. Antimicrobial susceptibility testing revealed high resistance to ertapenem (95.8%), meropenem (91.7%), and imipenem (87.5%), while 83.3% of CR-hvKP isolates exhibited a multidrug-resistant phenotype. Genomic analysis identified blaNDM (58.3%) as the predominant carbapenemase gene, followed by blaOXA-48-like (41.7%) and blaKPC (20.8%), while 33.3% of isolates carried two or more carbapenemase genes. Virulence profiling demonstrated a high prevalence of iucA (83.3%), ybt (75.0%), rmpA (66.7%), rmpA2 (58.3%), and iroB (54.2%). Multilocus sequence typing revealed substantial genetic diversity, with ST11 (33.3%) as the predominant lineage, followed by ST147 (20.8%), ST15 (16.7%), and ST23 (12.5%). Core-genome SNP analysis further demonstrated genetically distinct lineages with clustering of closely related isolates. Overall, the findings highlight the concerning convergence of carbapenem resistance and hypervirulence within high-risk K. pneumoniae clones. Continuous genomic surveillance, antimicrobial stewardship, and strengthened infection-control measures are essential to limit the emergence and dissemination of CR-hvKP.
Zitieren
APA
Afra, Bukhari, N. T., Nasir, M. A., Hayat, O., Kalim, M., Usman, M., Qazi, I. I., & Rashid, F. (2026). Genomic Investigation of Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae: Resistance, Virulence, and Genetic Diversity. Indus Journal of Bioscience Research, 4(3.1), 70-75. https://doi.org/10.70749/ijbr.v4i3.1.3354
Vancouver
Afra, Bukhari NT, Nasir MA, Hayat O, Kalim M, Usman M, et al. Genomic Investigation of Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae: Resistance, Virulence, and Genetic Diversity. Indus Journal of Bioscience Research. 2026;4(3.1):70-75. doi:10.70749/ijbr.v4i3.1.3354
BibTeX
@article{Afra2026,
author = {Afra and Bukhari, Nain Tara and Nasir, Muhammad Abdullah and Hayat, Obaid and Kalim, Muska and Usman, Muhammad and Qazi, Isbah Imtiaz and Rashid, Faiza},
title = {Genomic Investigation of Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae: Resistance, Virulence, and Genetic Diversity},
journal = {Indus Journal of Bioscience Research},
year = {2026},
volume = {4},
number = {3.1},
pages = {70--75},
doi = {10.70749/ijbr.v4i3.1.3354}
}
EUVIMED